An assessment of clinical continuous glucose monitoring targets for older and high-risk people living with type 1 diabetes
O’Neal DN, Cohen O, Vogrin S, et al.
Diabetes Technol Ther. Pub. online 31 Oct 2022
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Urva S, Coskun T, Loh MT, et al.
The Lancet. Pub. online 27 Oct 2022.
Leggi
Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the Clinical Islet Transplantation Consortium: the CIT-08 study
Rickels MR, Eggerman TL, Bayman L, et al.
Diabetes Care. 2022;dc212688
Leggi
Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials
Wen J, Yi Z, Chen Y et, al.
BMC Med. 2022;20(1):402.
Leggi
Relationship between daytime vs nighttime continuous glucose monitoring metrics with A1C in Adults with Type 1 Diabetes
Shah NV, Akturk HK, Vigers T, et al.
Diabetes Technol Ther. Pub. online 28 Oct 2022.
Leggi
Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?
Desoye G, Ringholm L, Damm P, et al.
Diabetologia. Pub. online 26 Oct 26.
Leggi
Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
Mora-Ortiz M, Alcala-Diaz JF, Rangel-Zuñiga OA, et al.
BMC Med. 2022;20(1):37.
Leggi
A statistical approach for assessing the compliance of integrated continuous glucose monitoring systems with FDA accuracy requirements
Stephan P, Eichenlaub M, Waldenmaier V, et al.
Diabetes Technol Ther. Pub. online 28 Oct 2022.
Leggi
Comparative effectiveness of empagliflozin vs liraglutide or sitagliptin in older adults with diverse patient characteristics
Htoo PT, Tesfaye H, Schneeweiss S, et al.
JAMA Netw Open. 2022;5(10):e2237606.
Leggi
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
Biegus J, Voors AA, Collins SP, et al.
Eur Heart J. 2022;ehac530.
Leggi